Literature DB >> 1400563

Establishment and characterization of a new human oestradiol- and progesterone-receptor-positive mammary carcinoma serially transplantable in nude mice.

H Naundorf1, I Fichtner, B Büttner, J Frege.   

Abstract

A human mammary carcinoma originating from a postmenopausal patient was successfully transplanted into nude mice. According to the adopted criteria the tumour proved to be oestradiol- and progesterone-receptor-positive. Histological studies of the patient tumour revealed a ductal invasive mammary carcinoma with 80% tubular growth pattern. Following transplantation the adenoid structures decreased to 30%; the mitosis rate and grade of malignancy increased. Treatment of the nude mice with 20 micrograms oestradiol benzoate/mouse caused a loss of the oestradiol receptor of the mammary carcinoma. The mammary carcinoma 3366 can be used for testing of antineoplastic substances, antihormones and for studies in regard to down-regulation or blocking of hormone receptors and possible consequences for therapies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400563     DOI: 10.1007/bf01209485

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  10 in total

Review 1.  [The importance of growth factors in endocrinology and oncology].

Authors:  K Rudolf
Journal:  Zentralbl Gynakol       Date:  1989

2.  The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.

Authors:  R Clarke; N Brünner; D Katz; P Glanz; R B Dickson; M E Lippman; F G Kern
Journal:  Mol Endocrinol       Date:  1989-02

3.  Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam.

Authors: 
Journal:  Eur J Cancer       Date:  1973-05       Impact factor: 9.162

4.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

5.  Breeding of nude mice under improved conventional conditions.

Authors:  H Naundorf; W Arnold
Journal:  Z Versuchstierkd       Date:  1981

6.  Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.

Authors:  K K Huff; C Knabbe; R Lindsey; D Kaufman; D Bronzert; M E Lippman; R B Dickson
Journal:  Mol Endocrinol       Date:  1988-03

7.  Phospholipids and fatty acids in breast cancer tissue.

Authors:  K Punnonen; E Hietanen; O Auvinen; R Punnonen
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

8.  Characterization of the T61 human breast carcinoma established in nude mice.

Authors:  N Brünner; G B Bastert; H S Poulsen; M Spang-Thomsen; S A Engelholm; L Vindeløv; A Nielsen; N Tommerup; F Elling
Journal:  Eur J Cancer Clin Oncol       Date:  1985-07

9.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

Authors:  D Yee; S Paik; G S Lebovic; R R Marcus; R E Favoni; K J Cullen; M E Lippman; N Rosen
Journal:  Mol Endocrinol       Date:  1989-03

10.  Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

Authors:  R A Hawkins; A L Tesdale; E D Anderson; P A Levack; U Chetty; A P Forrest
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  10 in total
  11 in total

1.  Establishment and characteristics of two new human mammary carcinoma lines serially transplantable in nude mice.

Authors:  H Naundorf; I Fichtner; G J Saul; W Haensch; B Büttner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Growth and metastasis of human breast cancers in athymic nude mice.

Authors:  M S Murthy; E F Scanlon; M L Jelachich; S Klipstein; R A Goldschmidt
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

3.  A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.

Authors:  Xiaomei Zhang; Sofie Claerhout; Aleix Prat; Lacey E Dobrolecki; Ivana Petrovic; Qing Lai; Melissa D Landis; Lisa Wiechmann; Rachel Schiff; Mario Giuliano; Helen Wong; Suzanne W Fuqua; Alejandro Contreras; Carolina Gutierrez; Jian Huang; Sufeng Mao; Anne C Pavlick; Amber M Froehlich; Meng-Fen Wu; Anna Tsimelzon; Susan G Hilsenbeck; Edward S Chen; Pavel Zuloaga; Chad A Shaw; Mothaffar F Rimawi; Charles M Perou; Gordon B Mills; Jenny C Chang; Michael T Lewis
Journal:  Cancer Res       Date:  2013-06-04       Impact factor: 12.701

4.  Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.

Authors:  I Fichtner; R Reszka; S R Goan; H Naundorf
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

5.  Establishment and characteristics of two new human mammary carcinoma lines in nude mice with special reference to the estradiol receptor status and the importance of stroma for in vivo and in vitro growth.

Authors:  H Naundorf; I Fichtner; B Elbe; G J Saul; W Haensch; W Zschiesche; S Reinecke
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.

Authors:  I Fichtner; R Zeisig; H Naundorf; S Jungmann; D Arndt; G Asongwe; J A Double; M C Bibby
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 7.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Authors:  Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

8.  Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives.

Authors:  H Naundorf; E C Rewasowa; I Fichtner; B Büttner; M Becker; M Görlich
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.624

9.  Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis.

Authors:  C Niemann; V Brinkmann; E Spitzer; G Hartmann; M Sachs; H Naundorf; W Birchmeier
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

10.  Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas.

Authors:  H Naundorf; K Parczyk; W Zschiesche; S Reinecke; B Büttner; G J Saul; B Sinn; I Fichtner
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.